Stifel Financial Corp Grows Stake in Chemed Co. (NYSE:CHE)

Stifel Financial Corp grew its position in Chemed Co. (NYSE:CHE) by 1.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 26,996 shares of the company’s stock after buying an additional 273 shares during the quarter. Stifel Financial Corp owned 0.18% of Chemed worth $16,224,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in CHE. American National Bank & Trust bought a new stake in Chemed during the 3rd quarter valued at $61,000. GAMMA Investing LLC lifted its stake in shares of Chemed by 60.5% during the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after purchasing an additional 52 shares during the last quarter. Quarry LP boosted its position in Chemed by 721.7% during the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares in the last quarter. Sound Income Strategies LLC purchased a new position in Chemed in the third quarter valued at about $201,000. Finally, Farther Finance Advisors LLC raised its holdings in Chemed by 2,314.3% in the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after purchasing an additional 324 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th. Royal Bank of Canada lowered their target price on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

Insiders Place Their Bets

In other Chemed news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 11.61 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now owns 103,735 shares in the company, valued at $62,117,555.35. The trade was a 1.89 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,132 shares of company stock valued at $3,003,502. 3.32% of the stock is owned by company insiders.

Chemed Stock Performance

Shares of NYSE CHE opened at $546.24 on Wednesday. Chemed Co. has a fifty-two week low of $523.33 and a fifty-two week high of $654.62. The company has a market cap of $8.22 billion, a PE ratio of 27.60, a P/E/G ratio of 2.34 and a beta of 0.46. The business has a 50-day simple moving average of $572.96 and a two-hundred day simple moving average of $564.91.

Chemed (NYSE:CHE) last released its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million during the quarter, compared to analyst estimates of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter last year, the business earned $5.32 earnings per share. On average, sell-side analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a $0.50 dividend. The ex-dividend date was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. Chemed’s dividend payout ratio (DPR) is 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.